EZH2 and cancer: Li et al. elucidated a SOX4-dependent epithelial–mesenchymal transition (EMT)-inducing mechanism underlying MTA1-driven cancer metastasis and suggested a widespread TGF-β-MTA1-SOX4-EZH2 signaling axis that drives the EMT in various cancers [29].